Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain-containing protein 55 (ANKRD55) is a nuclear protein that plays a significant role in autoimmune diseases, particularly multiple sclerosis and rheumatoid arthritis[1][3]. The protein contains ankyrin repeat domains, which are common protein-protein interaction platforms, allowing ANKRD55 to function in complex with other proteins[2]. ANKRD55 produces three different messenger RNA transcripts, with genetic variants associated with multiple sclerosis greatly increasing their production specifically in CD4+ T cells[1]. The protein localizes to nuclear speckles and is involved in various cellular processes including mitosis, likely through effects on mitotic spindle dynamics[2]. ANKRD55 is regulated by phosphorylation and interacts with numerous cellular proteins including 14-3-3 proteins, ribosomal proteins, cohesins, and tubulin isoforms[2]. In immune cells, ANKRD55 expression is modulated during monocyte-to-dendritic cell differentiation and is influenced by cytokines such as IL-4, GM-CSF, and retinoic acid agonists[3]. The protein appears to play a fundamental role in immune cell regulation, particularly in the deregulation of CD4+ T cells observed in multiple sclerosis, making it an important player in neuroinflammation processes[1]. Risk alleles of single nucleotide polymorphisms in the ANKRD55 gene are associated with higher expression levels in immune cells and increased susceptibility to autoimmune disorders[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain-containing protein 55 (ANKRD55).